Tokyo, Aug. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062409) titled 'Emotional and Social Experiences of Antifibrotic (AF) Therapy among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study' on Aug. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Boehringer Ingelheim Co., Ltd.
Condition:
Condition - Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis (PPF)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - What are the attitudes toward and experiences of the emotional and/or social impact of side effects associated with AF treatment among Japanese patients with ...